These results clearly demonstrate the therapeutic effect of anti‐MMR Nb‐IMDQ on LLC‐OVA tumors, likely mediated by a repolarization of MHC‐IIlow TAMs and an increased anti‐tumor T cell response. The gene discussed is HLA-C; the disease is neoplasm.